Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer
Escudier, B., Grunwald, V., Ravaud, A., Ou, Y.-C., Castellano, D., Lin, C.-C., Gschwend, J. E., Harzstark, A., Beall, S., Pirotta, N., Squires, M., Shi, M., Angevin, E.Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-3006
Date:
June, 2014
File:
PDF, 427 KB
english, 2014